Artivion AORT Medical devices — Total gross margin
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Artivion in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artivion's medical devices — total gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artivion's medical devices — total gross margin?
- Artivion (AORT) reported medical devices — total gross margin of $61.75M in Q1 2026.
- How has Artivion's medical devices — total gross margin changed year-over-year?
- Artivion's medical devices — total gross margin increased by 15.3% year-over-year, from $53.54M to $61.75M.
- What is the long-term trend for Artivion's medical devices — total gross margin?
- Over 4 years (2021 to 2025), Artivion's medical devices — total gross margin has grown at a 10.5% compound annual growth rate (CAGR), from $156.4M to $233.04M.
- What does medical devices — total gross margin mean?
- This metric measures the profitability of the medical devices segment by calculating the difference between total segment revenue and the direct costs of production. It provides insight into the segment's pricing power and manufacturing efficiency, indicating how much revenue is retained after accounting for the direct costs of goods sold.